Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in glioma
{{output}}
This study analyzed sequencing and clinical data from the Cancer Genome Atlas (TCGA) and gene expression synthesis, and used Chinese glioma Genome Atlas (CGGA) data for external validation. The expression of DCP2 in normal brain and tumor tissue was compared. ... ...
